Cordlife swings into the black on non-operating gains
CORDLIFE Group swung into a second-quarter profit of S$9.6 million, or 3.71 Singapore cents per share, as financial gains offset a decline in operating earnings.
Cordlife, which runs a cord blood bank, posted a net loss of S$3.0 million in the year-ago period. For the six months to December 2015, net profit stood at S$16.9 million, up from a S$6.5 million year-ago loss.
Revenue increased by 2 per cent to S$14.5 million during the quarter, but operating profit before tax fell 33.8 per cent to S$706,000.
The company sold shares in China Cord Blood Corp and convertible notes issued by China Cord Blood during the quarter. Those transactions led to Cordlife recognising fair value gains on its investment in China Cord Blood, including a S$7.3 million gain on fair-value change in derivatives compared to a S$4.7 million loss a year earlier.
Cordlife said that it expects its core business to remain profitable for fiscal 2016.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Beijing city to subsidise domestic AI chips, targets self-reliance by 2027
Hong Kong bourse regains favour on hopes of a market revival
Chinese sellers go to TikTok school to reach buyers abroad
Gold prices set for weekly decline ahead of US inflation data
Huawei’s new phone sports latest version of made-in-China chip
Meta’s earnings flop sparks US$400 billion sell-off in tech stocks